The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.
Article obtained from Photonics RSS Feed.
Prellis Biologics, developer of a holographic organ printing system, has received an $8.7 million investment led by Khosla Ventures. The investment is a Series A and comes after Prellis announced major milestones in tissue engineering.
Prellis structure transplanted alone is surrounded by single cell walled capillaries within two weeks of transplantation into immunocompetent mouse (left). Human tumor cells transplanted in Prellis structures grow rapidly, are highly vascularized, and demonstrate minimal hypoxia (right) (red = CD31, blue = DAPI, green = printed structure). Courtesy of Prellis Biologics.
The company recently reported positive results from the first animal transplantation of its 3D tissue scaffolds — called…READ MORE